
GLP-1 receptor agonists linked to lower alcohol-related hospitalizations in adults with alcohol use disorder.
A new study found that adults with alcohol use disorder (AUD) who started treatment with GLP-1 receptor agonists like semaglutide and tirzepatide had significantly fewer alcohol-related hospitalizations compared to those on other diabetes or obesity ...

